Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
- PMID: 26367776
- PMCID: PMC4569432
- DOI: 10.1371/journal.pone.0137429
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Abstract
The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and sensory disturbances. Studies on experimental autoimmune encephalomyelitis (EAE) animal models have led to a number of testable hypotheses including a hypothetical role of altered gut microbiota in the development of MS. To investigate whether gut microbiota in patients with MS is altered, we compared the gut microbiota of 20 Japanese patients with relapsing-remitting (RR) MS (MS20) with that of 40 healthy Japanese subjects (HC40) and an additional 18 healthy subjects (HC18). All the HC18 subjects repeatedly provided fecal samples over the course of months (158 samples in total). Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS. Furthermore, we found 21 species that showed significant differences in relative abundance between the MS20 and HC40 samples. On comparing MS samples to the 158 longitudinal HC18 samples, the differences were found to be reproducibly significant for most of the species. These taxa comprised primarily of clostridial species belonging to Clostridia clusters XIVa and IV and Bacteroidetes. The phylogenetic tree analysis revealed that none of the clostridial species that were significantly reduced in the gut microbiota of patients with MS overlapped with other spore-forming clostridial species capable of inducing colonic regulatory T cells (Treg), which prevent autoimmunity and allergies; this suggests that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Correcting the dysbiosis and altered gut microbiota might deserve consideration as a potential strategy for the prevention and treatment of MS.
Conflict of interest statement
Figures






Similar articles
-
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.Sci Rep. 2016 Jun 27;6:28484. doi: 10.1038/srep28484. Sci Rep. 2016. PMID: 27346372 Free PMC article.
-
A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.Gut Microbes. 2017 Nov 2;8(6):561-573. doi: 10.1080/19490976.2017.1353843. Epub 2017 Aug 4. Gut Microbes. 2017. PMID: 28708466 Free PMC article.
-
Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract.Sci Rep. 2020 Sep 16;10(1):15183. doi: 10.1038/s41598-020-72197-y. Sci Rep. 2020. PMID: 32938979 Free PMC article.
-
Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.Mediators Inflamm. 2018 Apr 2;2018:8168717. doi: 10.1155/2018/8168717. eCollection 2018. Mediators Inflamm. 2018. PMID: 29805314 Free PMC article. Review.
-
Gut microbiome in multiple sclerosis: The players involved and the roles they play.Gut Microbes. 2017 Nov 2;8(6):607-615. doi: 10.1080/19490976.2017.1349041. Epub 2017 Aug 3. Gut Microbes. 2017. PMID: 28696139 Free PMC article. Review.
Cited by
-
Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL/6 Mouse Model of Demyelination.Inflammation. 2021 Feb;44(1):334-343. doi: 10.1007/s10753-020-01339-1. Epub 2020 Sep 10. Inflammation. 2021. PMID: 32914363
-
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls.BMC Neurol. 2016 Sep 21;16(1):182. doi: 10.1186/s12883-016-0703-3. BMC Neurol. 2016. PMID: 27652609 Free PMC article.
-
Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients. 2023 Oct 24;15(21):4504. doi: 10.3390/nu15214504. Nutrients. 2023. PMID: 37960157 Free PMC article. Clinical Trial.
-
Environmental factors in autoimmune diseases and their role in multiple sclerosis.Cell Mol Life Sci. 2016 Dec;73(24):4611-4622. doi: 10.1007/s00018-016-2311-1. Epub 2016 Aug 4. Cell Mol Life Sci. 2016. PMID: 27491297 Free PMC article. Review.
-
Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.Arch Microbiol. 2021 Aug;203(6):2895-2910. doi: 10.1007/s00203-021-02276-9. Epub 2021 Mar 24. Arch Microbiol. 2021. PMID: 33763767 Review.
References
-
- Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347: 911–920. - PubMed
-
- Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007;61: 504–513. - PubMed
-
- Houzen H, Niino M, Hirotani M, Fukazawa T, Kikuchi S, Tanaka K, et al. Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan. J Neurol Sci. 2012;323: 117–122. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases